Dr. Wu is Director of Interventional Nephrology at Massachusetts General Hospital. His clinical research is focused on innovative approaches for the diagnosis and treatment of dysfunctional hemodialysis access, peripheral artery diseases, and renal artery stenosis. He has participated in a multi-center randomized clinical trial for comparing two different hemodialysis catheters. Future studies will address the role of specific drug modalities on modifying vascular access restenosis in collaboration with the Division's clinical research group.

Back to Top